Scilex Holding Company announced its board approved a dividend distribution of Semnur Pharmaceuticals common stock to Scilex shareholders and eligible equity holders. For each share of Scilex common stock held as of June 1, 2026, shareholders will receive one share of Semnur stock. Scilex holds about 186 million Semnur shares and plans to distribute approximately 10.7 million shares. The dividend payment date will be set within 60 days after the record date, subject to board approval and potential changes. This move reflects Scilex's strategy to reward shareholders with equity in its majority-owned subsidiary focused on non-opioid pain therapies.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
In 2026, Alphabet has delivered outstanding returns over one, three, and five years, contrasting with struggles faced by other hyperscalers. The semiconductor sector remains highly cyclical, impacting both business performance and stock prices. A com...
IES Holdings has been upgraded to a Buy rating due to a record backlog increase of 63% to $3.9 billion and ongoing capacity expansion. The company’s Communications and Infrastructure Solutions segments, which have higher margins and growth potential,...
Taiwan Semiconductor Manufacturing Company (TSMC) reported a 23.4% increase in second-quarter profit from the previous quarter, surpassing analyst estimates. The company's net income reached NT$706.56 billion ($39.45 billion), a record high for the f...
National Beverage faces stagnant growth as LaCroix volumes have declined for four straight years, reducing brand excitement. The stock trades at reasonable multiples reflecting muted growth and no clear catalysts for upside. Despite stable gross marg...
